176 studies found for:    "gastrointestinal stromal tumor"
Show Display Options
Rank Status Study
1 Recruiting Perioperative Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor
Condition: Gastrointestinal Stromal Tumor
Interventions: Drug: imatinib mesylate;   Procedure: conventional surgery
2 Completed Evaluation of Nilotinib In Patients With Advanced Gastrointestinal Stromal Tumor (GIST)
Condition: Gastrointestinal Stromal Tumor
Intervention: Drug: Nilotinib
3 Active, not recruiting Surgery in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal Tumor
Conditions: Gastrointestinal Stromal Tumor;   Metastatic Cancer
Intervention: Procedure: therapeutic conventional surgery
4 Active, not recruiting Imatinib Mesylate in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal Tumor
Conditions: Gastrointestinal Stromal Tumor;   Metastatic Cancer
Intervention: Drug: imatinib mesylate
5 Completed Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor
Condition: Gastrointestinal Stromal Tumor
Interventions: Drug: imatinib mesylate;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy
6 Active, not recruiting Imatinib Mesylate in Treating Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumor
Condition: Gastrointestinal Stromal Tumor
Intervention: Drug: imatinib mesylate
7 Active, not recruiting Imatinib Mesylate or Observation Only in Treating Patients Who Have Undergone Surgery for Localized Gastrointestinal Stromal Tumor
Condition: Gastrointestinal Stromal Tumor
Interventions: Drug: imatinib mesylate;   Procedure: adjuvant therapy
8 Terminated Imatinib Mesylate With or Without Surgery in Treating Patients With Metastatic Gastrointestinal Stromal Tumor That is Responding to Imatinib Mesylate
Condition: Gastrointestinal Stromal Tumor
Interventions: Drug: imatinib mesylate;   Procedure: therapeutic conventional surgery
9 Terminated Imatinib Mesylate and Sunitinib in Treating Patients With Gastrointestinal Stromal Tumors
Condition: Gastrointestinal Stromal Tumor
Interventions: Drug: imatinib mesylate;   Drug: sunitinib malate;   Other: pharmacological study
10 Completed S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors
Condition: Gastrointestinal Stromal Tumor
Intervention: Drug: temozolomide
11 Active, not recruiting Dasatinib as First-Line Therapy in Treating Patients With Gastrointestinal Stromal Tumors
Condition: Gastrointestinal Stromal Tumor
Intervention: Drug: dasatinib
12 Unknown  Study of Tumor Samples in Patients Undergoing Treatment for Gastrointestinal Stromal Tumors on Clinical Trial ACOSOG-Z9001
Condition: Gastrointestinal Stromal Tumor
Interventions: Genetic: mutation analysis;   Genetic: polymorphism analysis;   Other: laboratory biomarker analysis
13 Active, not recruiting Five Year Adjuvant Imatinib Mesylate (Gleevec®) in Gastrointestinal Stromal Tumor (GIST)
Condition: Gastrointestinal Stromal Tumor (GIST)
Intervention: Drug: imatinib mesylate
14 Completed Evaluate the Efficacy of AMG 706 to Treat Advanced Gastrointestinal Stromal Tumors
Condition: Advanced Gastrointestinal Stromal Tumor
Intervention: Drug: AMG 706
15 Recruiting Study of Hsp90 Inhibitor AUY922 for the Treatment of Patients With Refractory Gastrointestinal Stromal Tumor
Condition: Gastrointestinal Stromal Tumor
Intervention: Drug: AUY922
16 Active, not recruiting
Has Results
Sorafenib in Treating Patients With Malignant Gastrointestinal Stromal Tumor That Progressed During or After Previous Treatment With Imatinib Mesylate and Sunitinib Malate
Condition: Gastrointestinal Stromal Tumor
Intervention: Drug: sorafenib tosylate
17 Active, not recruiting
Has Results
Regorafenib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor
Condition: Gastrointestinal Stromal Tumor
Intervention: Drug: regorafenib
18 Completed Nilotinib Pharmacokinetics (PK) in Gastrointestinal Stromal Tumor (GIST)
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: Nilotinib
19 Completed
Has Results
A Study To Assess The Safety And Efficacy Of SU11248 In Patients With Gastrointestinal Stromal Tumor(GIST)
Condition: Gastrointestinal Stromal Tumor
Interventions: Drug: Placebo;   Drug: SU011248
20 Completed Imatinib Mesylate in Treating Patients With Gastrointestinal Stromal Tumor That Has Been Completely Removed During Surgery
Condition: Gastrointestinal Stromal Tumor
Interventions: Drug: imatinib mesylate;   Other: laboratory biomarker analysis

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years